|
|||||
|
|
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study |
|
| Authors: | Hensley Martee L Blessing John A Degeest Koen Abulafia Ovadia Rose Peter G Homesley Howard D |
| Affiliation: | Memorial Sloan-Kettering Cancer Center, Department of Medical Oncology, 1275 York Avenue, New York, NY 10021, USA. hensleym@mskcc.org |
| Abstract: | |
| Keywords: | Uterine leiomyosarcoma Gemcitabine Docetaxel |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |